Browsing Category

Top Industry News

7105 posts

Recipharm Divests Mfg Sites and Completes Spinout of Drug Delivery Business
By

By
Recipharm, a CDMO of drug substances and drug products, reports that Blue Wolf Capital Partners, a US-based private equity firm, has committed, subject to regulatory clearances, to acquire seven of its…

Genmab To Acquire ProfoundBio for $1.8 Bn
By

By
Genmab, a Copenhagen, Denmark-based bio/pharmaceutical company, has agreed to acquire ProfoundBio, a Seattle, Washington-based bio/pharmaceutical company, for $1.8 billion.   ProfoundBio is a privately owned clinical-stage biotechnology company developing antibody drug…

Bora Pharmaceuticals Completes $210-M Acquisition of Upsher-Smith
By

By
Bora Pharmaceuticals, a Taipei City, Taiwan-based pharmaceutical company and CDMO of drug products, has completed its acquisition of Upsher-Smith Laboratories, a pharmaceutical company focused on specialty brands and generics, for…

Lonza To Acquire Large-Scale Biologics Mfg Site from Roche for $1.2 Bn 
By

By
Lonza has agreed to acquire a large-scale biologics manufacturing site in Vacaville, California, from Roche’s Genentech for $1.2 billion.  The Vacaville facility currently has a total bioreactor capacity of approximately…

BMS Completes $14-Bn Acquisition of Karuna Therapeutics 
By

By
Bristol Myers Squibb (BMS) has completed its $14-billion acquisition of Karuna Therapeutics, a Boston-based bio/pharmaceutical company specializing in neuroscience-based drugs. The acquisition was first announced in December 2023. The deal…

Gilead Completes $4.3-Bn Acquisition of CymaBay Therapeutics 
By

By
Gilead has completed its $4.3-billion acquisition of CymaBay Therapeutics, a Newark, California-based clinical-stage bio/pharmaceutical company. The deal was announced in February 2024.  CymaBay’s lead candidate is seladelpar, an oral drug…

AstraZeneca To Acquire Fusion Pharmaceuticals & Amolyt Pharma in Combined $3.4-Bn Deals 
By

By
AstraZeneca has agreed to acquire two companies in two separate deals: Fusion Pharmaceuticals, a Hamilton, Ontario, Canada-based clinical-stage bio/pharmaceutical company, in a $2.4-deal billion (includes $2 billion upfront), and Amolyt…

J&J Completes $2-Bn Acquisition of ADC Company Ambrx Biopharma 
By

By
Johnson & Johnson (J&J) has completed its acquisition of Ambrx Biopharma, a La Jolla, California-based bio/pharmaceutical company, for a total equity value of $2.0 billion. The deal was announced in…

Novo Nordisk To Acquire Cardior Therapeutics in $1.1-Bn Deal 
By

By
Novo Nordisk has agreed to acquire Cardior Pharmaceuticals, a Hanover, Germany-based bio/pharmaceutical company, in an EUR 1.025 billion ($1.1 billion) deal. The deal includes an undiclosed upfront payment and additional…

BMS Investing $400 M in New Sterile Drug-Product Mfg Facility 
By

By
Bristol Myers Squibb (BMS) has announced a $400-million investment at its Dublin, Ireland (Cruiserath) campus for the build and design of a sterile drug-product (SDP) manufacturing facility.   This will be…